Back to search

University of Thessaly (UTH)

Γλυκοκορτικοειδή και ανοσοποιητικό σύστημα: επιπτώσεις στην ανοσοθεραπεία του καρκίνου

Abstract

dc:description

The inherent ability of Natural Killer (NK) cell to directly target tumor cells renders them a powerful tool in cancer immunotherapy. However, our limited understanding of the dynamic and pleiotropic nature of NK cells has not allowed for the efficient exploitation of the anti-tumor features of these cells until now. Therefore, the identification and characterization of cell-intrinsic and cell-extrinsic factors, which regulate the development and function of NK cells, is of great importance for the development of successful NK-cell-based immunotherapies against human cancers. Glucocorticoids, naturally present not only in peripheral blood but also within the sites of lymphocytes differentiation, have been reported either to stimulate or suppress immune responses. In the present study, we provide evidence supporting that common glucocorticoids used in clinical practice, promote proliferation of IL-15-activated human NK cell without impairing their cytotoxic activity, cytokine production potential and expression of activating receptors. Moreover, we present data supportive of the differential action of glucocorticoids on the two main subpopulations of NK cells, in terms of cell proliferation and homing capacity. Glucocorticoids preferentially induced the proliferation of a more immature cell population characterized as CD16-NKG2A+KIRlow/-CD57-CD94high. In addition, the surface expression of CXCR3 and CXCR4 was significantly increased on IL-15/GC stimulated NK cells favoring their migration capacity toward sites of inflammation and the bone marrow, respectively. Furthermore, CD16- NK cells exhibited enhanced susceptibility to IL-15 induced apoptosis, which was prevented by the concurrent presence of glucocorticoids. This protective effect of glucocorticoids was correlated with elevated expression levels of anti-apoptotic factors BCL2 and BCLxL, and reduced levels of the pro-apoptotic factor BIM. The aforementioned synergistic effect of glucocorticoids and IL-15 might play a significant role in the homeostasis of peripheral NK cells. The pre-exposure of NK cells to even physiological levels of glucocorticoids impaired their proliferation potential, yet the presence of minimal amounts of IL-15 during the pre-exposure period could counteract the inhibitory effect of glucocorticoids. Finally, we provide evidence for the role of glucocorticoids in the acceleration of cell cycle progression of IL-15 stimulated CD16- NK cells.These findings underline a novel mechanism of immune-modulation mediated by glucocorticoids, which might have implications for development of more efficient NK-cell-based immunotherapeutic strategies.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2013

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Μουστάκη, Αρντιάνα
  • Moustaki, Ardiana

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/29240

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Μουστάκη, Αρντιάνα; Moustaki, Ardiana. Γλυκοκορτικοειδή και ανοσοποιητικό σύστημα: επιπτώσεις στην ανοσοθεραπεία του καρκίνου. University of Thessaly (UTH), 2013. http://hdl.handle.net/10442/hedi/29240